Clinical Trial Update: VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating VNP40101M with temozolomide in progressive or relapsed malignant glioma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• VNP40101M

Snippet

Sponsor: Northwestern University | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: TERMINATED